NADMED
Therapeutics & Diagnostics · Helsinki
Metabolic-level diagnostics — measurement of NAD coenzymes (kits) for research and health.
In market📍 Helsinki📅 Founded 2022🎓 Univ. of Helsinki💶 €3.5M (Series A, 2024)
The row
- Stage
- In market — Product is being sold
- Location
- Helsinki
- Founded
- 2022
- Research origin
- Univ. of Helsinki
- Business ID
- 3259265-3 · Finnish trade register
- Funding
- €3.5M (Series A, 2024)
Links
Where this sits on the map
NADMED is one of 33 companies in Therapeutics & Diagnostics. The others:
How this row was decided
Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗